Mega Doctor News
- Advertisement -
Medical News Today
Over the last few years, glucagon-like peptide-1 (GLP-1) receptor agonists have been growing in popularity for not only treating type 2 diabetes but also for weight loss.
Recent surveys show that about one in every eight adults in the United States — or 12% — are currently taking a GLP-1 medication like Wegovy or Zepbound for weight loss or treatment of a chronic condition.
- Advertisement -
Follow the link below to Medical News Today to read the full story:
https://www.medicalnewstoday.com/articles/glp-1s-dont-work-for-everyone-why-and-what-to-do
Information source: https://www.medicalnewstoday.com
- Advertisement -
